May 10, 2026

AuthChart

Conviction level: Lean Yes (4 out of 5). Promising potential

This is a real, stupidly common pain. Micro-clinics and solo BCBAs pour therapy hours into kids and families, then spend off-hours unpicking denials because authorizations don’t line up with CPT codes or notes are fluff. It’s not academic — it’s cashflow, trust, and burnout.

Sign up free to unlock the full analysis

Sign up to unlock

VC Panel Verdict

Marcus - The Hawk
Lean Yes

Marcus

The Hawk

High-pain workflow, but pricing and GTM assumptions look loose for micro-clinics; risk of long payback driven by paid acquisition + trust/compliance friction. Needs proof of low CAC and fast activation-to-paid conversion.

Amara - The Visionary
Lean Yes

Amara

The Visionary

A textbook orchestration play. It leverages commodity AI (OCR, LLM) to solve a high-friction, high-cost vertical problem without the liability of building proprietary infrastructure. The architecture is lean, the time-to-value is immediate, and the data flywheel potential from user-accepted rewrites is significant.

Sofia - The Empath
Lean Yes

Sofia

The Empath

This is a product people will immediately understand and want to share. The aha moment hits in under 30 seconds when a BCBA sees their vague note transformed into audit-proof documentation. Natural viral mechanics through tight-knit ABA communities. Minor friction in trust-building around AI accuracy.

Market & Execution Scores

Timing
0/10
Execution
0/10
Opportunity
0/10
Revenue
0/10

Market Sizing

TAM (Total Addressable Market)
$X.XB
SAM (Serviceable Addressable Market)
$X.XM
SOM (Serviceable Obtainable Market)
$X.XM

Revenue Potential

ARR Growth Projection

Year 1

$XXX,XXX

Year 2

$X.XM

Year 3 Target

$XX.XM

Pricing Tiers

X tiers

Free → Paid Conversion

XX%

Annual Retention

XX%